Trial
NCT05552859
Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Type 2 Diabetes Mellitus
Intervention
Insulin glargine 300 U/mL
Why stopped
Sponsor decision to cancel trial due to poor recruitment/ severe recruitment delay and not related to safety concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-08